Centre forms committee to examine WHO details on 66 kid deaths in The Gambia
Darpan News Desk IANS, 12 Oct, 2022 11:00 AM
New Delhi, Oct 12 (IANS) The Centre has formed a four-member panel to examine the detailed report shared by the World Health Organisation on 66 children's deaths in The Gambia reportedly after using Indian-made medicines.
"The committee will examining and analysing adverse event reports, causal relationship, and all related details shared by WHO. After examining, the committee will suitably advise and recommend the Drug Controller General of India (DCGI) about further course of action. The committee may co-opt any other technical expert as deemed necessary, an official source told IANS.
The WHO had issued an alert on four India-made cough and cold syrups "potentially linked with acute kidney injuries and 66 deaths among children in Gambia".
The committee will be chaired by Dr Y.K Gupta, Vice Chairperson, Standing National Committee on Medicines. The other members are Dr Pragya D. Yadav, NIV, ICMR, Pune, Dr Arti Bahl, Division of Epidemiology, NCDC, New Delhi, and A.K. Pradhan, JDC(I), CDSCO.
The WHO has informed that as per the tentative results received by it, out of the 23 samples of the products under reference which were tested, four samples have been found to contain Diethylene Glycol/Ethylene Glycol.
However, the global health body has not yet made available the certificate of analysis. It has informed that the same will be made available in near future. The exact one to one causal relation of death has not yet been provided by the WHO to the Central Drugs Standard Control Organisation (CDSCO) although it has requested the global health body twice in this regard, sources told IANS.
After the CDSCO launched a detailed investigation to ascertain the facts, the preliminary enquiry has revealed that Maiden Pharmaceutical Ltd, Sonepat, Haryana is a manufacturer licensed by the State Drug Controller for products Promethazine Oral Solution BP, Kofexnalin Baby Cough Syrup, MaKoff Baby Cough Syrup, and MaGrip n Cold Syrup under reference, and holds manufacturing permission for these products for export only. The company has manufactured and exported these products only to The Gambia.
Meanwhile, the CDSCO and State Drug Controller Haryana have stopped all the manufacturing activities of Maiden Pharmaceuticals Ltd at Sonepat on October 11 on grounds of deficiencies found on local inspection.
The Central Bureau of Investigation (CBI) said it received an email from Punjab Police with an attached letter of May 19 about Brar only on May 30, a day after Moosewala was shot dead.
Murder of Punjabi singer Shubhdeep Singh, popularly known as Sidhu Moosewala, allegedly on behalf of the Lawrence Bishnoi gang, took place on May 29, 2022. Goldy Brar is a prime accused in the case. He has been accused of hiring gangsters to eliminate Moosewala.
The official informed that they received a call about the fire incident around 5.00 a.m. at the Main Tikona Park, Jamia Nagar in South-East Delhi after which as many as 11 fire tenders were immediately pressed into service. The cause of the fire is yet to be ascertained.
The BSF is interrogating the arrested smugglers. This is the second major incident of drugs being caught on the border in the last one week. Earlier also drug was dropped into India by using drones.
Donning T-shirts with pictures of Moosewala printed on them with the message 'Legends never die', some of the fans gathered to attend the 'bhog' ceremony of the singer.
A spokesperson for the police said on May 19, 10 days before the killing of Moosewala, it had already sent the proposal to the Central Bureau of Investigation (CBI) to issue Red Corner notice against Brar, which will pave the way for his extradition to India.
